IV. Current status and future perspectives in low-grade serous cancer of the ovary

John Siemon, David Gershenson, Brian Slomovitz, Matthew Schlumbrecht

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)247-255
Number of pages9
JournalJapanese Journal of Cancer and Chemotherapy
Volume45
Issue number2
StatePublished - Feb 1 2018

Fingerprint

Ovarian Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

IV. Current status and future perspectives in low-grade serous cancer of the ovary. / Siemon, John; Gershenson, David; Slomovitz, Brian; Schlumbrecht, Matthew.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 45, No. 2, 01.02.2018, p. 247-255.

Research output: Contribution to journalArticle

Siemon, John ; Gershenson, David ; Slomovitz, Brian ; Schlumbrecht, Matthew. / IV. Current status and future perspectives in low-grade serous cancer of the ovary. In: Japanese Journal of Cancer and Chemotherapy. 2018 ; Vol. 45, No. 2. pp. 247-255.
@article{a2ed393a4a4d45ca993e654272a222c1,
title = "IV. Current status and future perspectives in low-grade serous cancer of the ovary",
author = "John Siemon and David Gershenson and Brian Slomovitz and Matthew Schlumbrecht",
year = "2018",
month = "2",
day = "1",
language = "English (US)",
volume = "45",
pages = "247--255",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "2",

}

TY - JOUR

T1 - IV. Current status and future perspectives in low-grade serous cancer of the ovary

AU - Siemon, John

AU - Gershenson, David

AU - Slomovitz, Brian

AU - Schlumbrecht, Matthew

PY - 2018/2/1

Y1 - 2018/2/1

UR - http://www.scopus.com/inward/record.url?scp=85045874000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045874000&partnerID=8YFLogxK

M3 - Article

VL - 45

SP - 247

EP - 255

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 2

ER -